"A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis." by Steven Fishbane

Selected Works of Srinivas Hariachar, MD

Article

A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis.

American Journal of Kidney Diseases (2010)

Steven Fishbane, Winthrop-University Hospital
James Delmez, Washington University in St. Louis
Wadi N. Suki, Baylor College of Medicine
Srinivas K. Hariachar, Outcomes Research International Inc, Hudson, FL
Jeremy Heaton, Genzyme
Scott Chasan-Taber, Genzyme
Melissa A. Plone, Genzyme
Sharon Moe, Indiana University

Link

Disciplines

Publication Date

February 1, 2010

DOI

10.1053/J.AJKD.2009.10.051

Citation Information

Steven Fishbane, James Delmez, Wadi N. Suki, Srinivas K. Hariachar, et al.. "A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis." American Journal of Kidney Diseases Vol. 55 Iss. 2 (2010) p. 307 - 315
Available at: http://works.bepress.com/srinivas-hariachar/3/